All Access Articles |
- Navigating BBIO – Key Insights for Investors | 2025-06-30 | PHARMACEUTICAL
- Unlocking Key Insights into BridgeBio Pharma | 2025-05-14 | PHARMACEUTICAL
- BridgeBio Pharma 10-Q Report Reveals Diverse Pipeline and FDA Approvals | 2025-04-30 | PHARMACEUTICAL
- Analyzing the Reasons Behind BBIO's Stock Decline | 2025-02-25 | PHARMACEUTICAL
- BridgeBio Pharma – Key Insights as Stock Surges | 2025-02-14 | PHARMACEUTICAL
- FDA Approves BridgeBio Pharma's ATTR-CM Treatment | 2024-11-25 | PHARMACEUTICAL
- BridgeBio Pharma Reports Positive Results in Phase 2 Trial of Infigratinib for Achondroplasia | 2024-06-06 | PHARMACEUTICAL
- It's Time For a Quick Look at BridgeBio Pharma's Fundamentals. | 2024-05-15 | PHARMACEUTICAL
- Quick Briefing on BridgeBio Pharma | 2023-12-02 | UNITED STATES
- What Are the Fundamentals Of BBIO? | 2023-11-29 | UNITED STATES
- BBIO Investors - Our Quick Report For You. | 2023-10-30 | UNITED STATES
- Here Are the Facts You Need to Understand BBIO | 2023-08-02 | PHARMACEUTICAL